Pacira BioSciences Inc (PCRX)
26.35
+0.85
(+3.33%)
USD |
NASDAQ |
Apr 26, 16:00
26.35
0.00 (0.00%)
After-Hours: 20:00
Pacira BioSciences Cash from Operations (TTM): 154.65M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 154.65M |
| September 30, 2023 | 149.10M |
| June 30, 2023 | 147.32M |
| March 31, 2023 | 133.62M |
| December 31, 2022 | 145.27M |
| September 30, 2022 | 126.45M |
| June 30, 2022 | 144.08M |
| March 31, 2022 | 144.41M |
| December 31, 2021 | 125.72M |
| September 30, 2021 | 149.17M |
| June 30, 2021 | 128.66M |
| March 31, 2021 | 82.90M |
| December 31, 2020 | 77.03M |
| September 30, 2020 | 56.27M |
| June 30, 2020 | 34.84M |
| March 31, 2020 | 73.23M |
| December 31, 2019 | 70.52M |
| September 30, 2019 | 65.84M |
| June 30, 2019 | 64.11M |
| March 31, 2019 | 55.06M |
| December 31, 2018 | 48.87M |
| September 30, 2018 | 44.58M |
| June 30, 2018 | 25.14M |
| March 31, 2018 | 15.09M |
| December 31, 2017 | 17.78M |
| Date | Value |
|---|---|
| September 30, 2017 | 18.20M |
| June 30, 2017 | 32.70M |
| March 31, 2017 | 36.58M |
| December 31, 2016 | 33.45M |
| September 30, 2016 | 33.10M |
| June 30, 2016 | 26.13M |
| March 31, 2016 | 25.77M |
| December 31, 2015 | 28.02M |
| September 30, 2015 | 25.75M |
| June 30, 2015 | 29.39M |
| March 31, 2015 | 30.43M |
| December 31, 2014 | 26.56M |
| September 30, 2014 | 4.94M |
| June 30, 2014 | -13.26M |
| March 31, 2014 | -34.78M |
| December 31, 2013 | -43.84M |
| September 30, 2013 | -58.12M |
| June 30, 2013 | -59.46M |
| March 31, 2013 | -66.37M |
| December 31, 2012 | -70.13M |
| September 30, 2012 | -56.55M |
| June 30, 2012 | -53.86M |
| March 31, 2012 | -44.56M |
| December 31, 2011 | -31.00M |
| September 30, 2011 | -29.24M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
34.84M
Minimum
Jun 2020
154.65M
Maximum
Dec 2023
109.12M
Average
126.45M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Dynavax Technologies Corp | 100.56M |
| Arbutus Biopharma Corp | -85.94M |
| Chimerix Inc | -69.09M |
| Karyopharm Therapeutics Inc | -92.72M |
| FibroGen Inc | -315.02M |